A decreasing incidence of ovarian carcinoma in Israel

International Journal of Gynecological Cancer

Volumn 16, Issue 1, 2006, Pages 41-44

  Menczer, J ^a   Liphshitz, I ^b   Barchana, M ^b  

^a WOLFSON MEDICAL CENTER   (Israel)

^b National Cancer Registry   (Israel)

Author keywords

Epithelial ovarian carcinoma; Incidence; Israel

Indexed keywords

ADULT; AGED; ARTICLE; ASIA; CANCER INCIDENCE; CANCER REGISTRY; ETHNIC GROUP; FEMALE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; OVARY CARCINOMA; POPULATION; PRIORITY JOURNAL;

ADULT; AGE DISTRIBUTION; AGED; CARCINOMA; CONFIDENCE INTERVALS; FEMALE; HUMANS; INCIDENCE; ISRAEL; LINEAR MODELS; MIDDLE AGED; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PROBABILITY; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 33645338444     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00275.x     Document Type: Article

References (23)

1. Barchana M Andreev H Alon R. Israel cancer registry. Cancer in Israel. 1994.
2. Whittemore AS Harris R Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992 136 1184 203.
3. Statistical abstract of Israel 2002. No. 50 Central bureau of statistics publication. Jerusalem Government Press 2002.
4. Gwinn ML Lee NC Rhodes PH Layde PM Rubin GL. Pregnancy, breast feeding and oral contraceptives and the risk of ovarian cancer of epithelial cancer. J Clin Epidemiol 1990 43 559 68.
5. dos Santos Silva IS Swerdlow AJ. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancer in England and Wales and their relation to changing fertility and oral contraceptive use. Br J Cancer 1995 72 485 92.
6. Modan B Hartge P Hirsch-Yechezkel G et al. Oral contraceptives and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. J Natl Cancer Inst 2003 95 1072 8.
7. Olaitan A Mocroft A Jacobs I. Patterns in the incidence of age-related ovarian cancer in South East England 1967-1996. Br J Obstet Gynecol 2000 107 1094 6.
8. Laurvick CL Semmens JB Holman CD Leung YC. Ovarian cancer in Western Australia (1982-98): incidence, mortality and survival. Aust N Z J Public Health 2003 27 588 95.
9. Oriel KA Hartenbach EM Remington PL. Trends in United States ovarian cancer mortality. Obstet Gynecol 1999 93 30 3.
10. Runnebaum IB Stickeler E. Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol 2001 127 73 9.
11. Kliewer EV Smith KR. Ovarian cancer mortality among immigrants in Australia and Canada. Cancer Epidemiol Biomarkers Prev 1995 4 453 8.
12. Dunn JE. Cancer epidemiology in populations of the United States with emphasis on Hawaii and California and Japan. Cancer Res 1975 35 3240 5.
13. Freedman DM Dosemeci M McGlyn K. Sunlight and mortality from breast, ovarian, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med 2002 59 257 62.
14. Liu L Deapen D Bernstein L. Socioeconomic status and cancers of the female breast and reproductive organs: a comparison across racial/ethnic populations in Los Angeles County, California (United States). Cancer Causes Control 1998 9 369 80.
15. Mor-Yosef S Avraham R Schenker JG. Ovarian cancer in Israel, 1960-1989. Harefuah 1997 132 153 5.
16. Modan B Gak E Bar Sadeh-Bruchim R et al. High frequency of 185delAG BRCA1 mutation in ovarian cancer in Israel. JAMA 1996 276 1823 5.
17. Tobias DH Eng C McCurdy LD et al. Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients. Gynecol Oncol 2000 78 148 51.
18. Rutter JL Wacholder S Chetrit A et al. Gynecologic surgeries and risk of ovarian cancer in carriers and non-carriers of the BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study. J Natl Cancer Inst 2003 95 1072 8.
19. Nugent D Salha O Balen AH Rutherford AJ. Ovarian neoplasia and subfertility treatments. Br J Obstet Gynaecol 1998 105 584 91.
20. Howe HL Wingo PA Thun MJ et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001 93 824 42.
21. Ioka A Tsukuma H Ajiki W Oshima A. Ovarian cancer incidence and survival by histologic type in Osaka, Japan. Cancer Sci 2003 94 292 6.
22. Hirotami T Kunio A Aya H Noboru K. Cancer statistics in Japan. Incidence, mortality and prognosis. Tokio, Japan Shinohoro Press 1993.
23. Mahdy NH Abdel-Fattah M Ghanem H. Ovarian cancer in Alexandria from 1988 to 1997: trends and survival. East Mediterr Health J 1999 5 727 39.